City of Hope was founded in 1913 and has expanded ever since to include a clinical research center, a hospital, the Beckman Research Institute of City of Hope, and a graduate medical school. City of Hope has been the grantee of extensive and generous federal and private grants which have contributed to the development of many therapies, including synthetic human insulin and hematopoietic cell transplantation.
The City of Hope Comprehensive Cancer Center is designated as a Comprehensive Cancer Center by the National Cancer Institute due to its focus on patient care, basic and clinical research, prevention, education, outreach and training. City of Hope is partnered with the Beckman Research Institute to provide further expertise in equipment, services, and consultation.
The City of Hope Comprehensive Cancer Center’s commitment to cutting edge research and patient-centered therapies continues to support its ranking in the US News and World Report as one of “America’s Best Hospitals.”
The integrated research environment provides collaboration of laboratory scientists and physicians within clinical, translational, and prevention studies. City of Hope has five cancer research programs focusing on molecular oncology, developmental cancer therapeutics, cancer immunotherapeutics, hematologic malignancies, and cancer control and populations sciences.
Radiation oncology, surgical oncology, clinical trials, chemotherapy, palliative care, state of the art diagnostics and imaging services, pathology, genetic counseling, hormone therapy, biological therapy, complementary and alternative medicine, nutrition and physical therapy, and comprehensive and preventive care are all options in the City of Hope Comprehensive Cancer Center cancer treatment program.